Atlas Trials

Milrinone Versus Placebo in Patients With Septic Shock

Clinical trial NCT05122884 · UNKNOWN

Trial details

NCT number
NCT05122884
Sponsor
Mahidol University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Septic ShockCardiac Output
Start date
2021-12-01
Primary completion
2024-12-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.